Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Gates Foundation

Global: To discover and develop improved pan-TB drug regimens effective against all forms of TB that are shorter, simpler, and safer

Last update: 2 days ago Last update: Jun 17, 2026

Details

Locations:USA
Start Date:Apr, 2026
End Date:Apr, 2028
Contract value: USD 8,999,245
Sectors:Health
 Health
Categories:Grants
Funding Agencies:
Gates Foundation
Date posted:Jun 17, 2026
Contracting authority:Gates Foundation

Associated funding

Associated experts

Description

Purpose: To discover and develop improved pan-TB drug regimens effective against all forms of TB that are shorter, simpler, and safer
Division: Global Health
Region served: GLOBAL
Grant topic: Tuberculosis
Duration (months): 24
Grantee location: New York, New York, United States

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.
Learn more about our membership benefits
Print